Operations in Canada and USA
Opportunity to purchase one of the premier probiotics and supplement manufacturers in North America. Probiotics can replace pharma-ceutical agents The increasing demand for probiotics has shown that customers prefer products with proven health benefits. The increasing evidence of health benefits associated with probiotics for health restoration has increased the customer expectations related to probiotics. Market research indicates a growth rate of 8.5% to 2027.
The Company is positioned well to capitalize on this anticipat-ed growth as the Company has manufacturing plants in both locations have capacity to increase production and the Canadi-an facility has another 10,000 square feet buildable. Additionally the Company just spent $1,000,000 to expand the Canadian production area. The Canadian location recently received the FDA certificate for manufacturing drugs.
Seeking an equity investment of $10,000,000 for 30% of the company (excluding Property)
Or an outright sale of the business.